Metabolic and Clinical Outcomes in Nondiabetic Individuals With the Metabolic Syndrome Assigned to Chlorthalidone, Amlodipine, or Lisinopril as Initial Treatment for Hypertension
Online-Only Appendix
Files in this Data Supplement:
- Appendix Figure 1. Randomization and Follow-up of Participants in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
- Appendix Figure 2. Mean Systolic and Diastolic Blood Pressure by Year During Follow Up in Participants With and Without Metabolic Syndrome (Without Diabetes)
- Appendix Figure 3. Combined Cardiovascular Disease by 2-Year Incident Diabetes Status, Metabolic Syndrome at baseline, and Randomized Treatment Group
- Appendix Figure Legends
This Article
-
Diabetes Care February 2008 vol. 31 no. 2 353-360
- AbstractFree
- Full Text
- Full Text (PDF)
- » Online-Only Appendix
Current Issue
From the Cover
- Driving mishaps among individuals with type 1 diabetes: a prospective study
- Projecting the future diabetes population size and related costs for the U.S.
- Prospective study of pre-gravid sugar-sweetened beverage consumption and the risk of gestational diabetes mellitus
- Are metabolically normal but obese individuals at lower risk for all-cause mortality?
